Rebound high-pressure headache after treatment of spontaneous intracranial hypotension: MRV study

Wouter I. Schievink, M. Marcel Maya, Stacey Jean-Pierre, Franklin G. Moser, Miriam Nuño, Barry D. Pressman

Research output: Contribution to journalArticle

Abstract

BackgroundRebound high-pressure headaches may complicate treatment of spontaneous intracranial hypotension (SIH), but no comprehensive study of such patients has been reported and little is known about its frequency and risk factors. We therefore studied patients undergoing treatment for SIH and performed magnetic resonance venography (MRV) to assess for cerebral venous sinus stenosis, a risk factor for idiopathic intracranial hypertension.MethodsWe studied a consecutive group of patients who underwent treatment for SIH. Rebound high-pressure headache was defined as a reverse orthostatic headache responsive to acetazolamide. MRV was obtained in all patients and lateral sinus stenosis was scored according to the system published by Higgins et al., with 0 being normal and 4 signifying bilateral signal gaps.ResultsThe mean age of the 46 men and 67 women was 45.9 years (range 13-71 years) at the time of onset of SIH. Rebound high-pressure headache was diagnosed in 31 patients (27.4%); 14% of patients with an MRV score of 0, 24% with a score of 1, and 46% with a score of 2 or 3 (p = 0.0092). Also, compared to SIH patients who did not develop rebound high-pressure headaches (n = 82), those with rebound high-pressure headaches were younger, more often female, and more often had an extradural CSF collection on spinal imaging.ConclusionsRebound high-pressure headache occurs in about one-fourth of patients following treatment of SIH and is more common in those with restriction of cerebral venous outflow.

Original languageEnglish (US)
Pages (from-to)93-100
Number of pages8
JournalNeurology: Clinical Practice
Volume9
Issue number2
DOIs
StatePublished - Apr 1 2019

Fingerprint

Intracranial Hypotension
Phlebography
Headache
Magnetic Resonance Spectroscopy
Pressure
Therapeutics
Pathologic Constriction
Transverse Sinuses
Pseudotumor Cerebri
Acetazolamide

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

Rebound high-pressure headache after treatment of spontaneous intracranial hypotension : MRV study. / Schievink, Wouter I.; Maya, M. Marcel; Jean-Pierre, Stacey; Moser, Franklin G.; Nuño, Miriam; Pressman, Barry D.

In: Neurology: Clinical Practice, Vol. 9, No. 2, 01.04.2019, p. 93-100.

Research output: Contribution to journalArticle

Schievink, Wouter I. ; Maya, M. Marcel ; Jean-Pierre, Stacey ; Moser, Franklin G. ; Nuño, Miriam ; Pressman, Barry D. / Rebound high-pressure headache after treatment of spontaneous intracranial hypotension : MRV study. In: Neurology: Clinical Practice. 2019 ; Vol. 9, No. 2. pp. 93-100.
@article{f3c0c43b3c6e471db028d2c8cda59285,
title = "Rebound high-pressure headache after treatment of spontaneous intracranial hypotension: MRV study",
abstract = "BackgroundRebound high-pressure headaches may complicate treatment of spontaneous intracranial hypotension (SIH), but no comprehensive study of such patients has been reported and little is known about its frequency and risk factors. We therefore studied patients undergoing treatment for SIH and performed magnetic resonance venography (MRV) to assess for cerebral venous sinus stenosis, a risk factor for idiopathic intracranial hypertension.MethodsWe studied a consecutive group of patients who underwent treatment for SIH. Rebound high-pressure headache was defined as a reverse orthostatic headache responsive to acetazolamide. MRV was obtained in all patients and lateral sinus stenosis was scored according to the system published by Higgins et al., with 0 being normal and 4 signifying bilateral signal gaps.ResultsThe mean age of the 46 men and 67 women was 45.9 years (range 13-71 years) at the time of onset of SIH. Rebound high-pressure headache was diagnosed in 31 patients (27.4{\%}); 14{\%} of patients with an MRV score of 0, 24{\%} with a score of 1, and 46{\%} with a score of 2 or 3 (p = 0.0092). Also, compared to SIH patients who did not develop rebound high-pressure headaches (n = 82), those with rebound high-pressure headaches were younger, more often female, and more often had an extradural CSF collection on spinal imaging.ConclusionsRebound high-pressure headache occurs in about one-fourth of patients following treatment of SIH and is more common in those with restriction of cerebral venous outflow.",
author = "Schievink, {Wouter I.} and Maya, {M. Marcel} and Stacey Jean-Pierre and Moser, {Franklin G.} and Miriam Nu{\~n}o and Pressman, {Barry D.}",
year = "2019",
month = "4",
day = "1",
doi = "10.1212/CPJ.0000000000000550",
language = "English (US)",
volume = "9",
pages = "93--100",
journal = "Neurology: Clinical Practice",
issn = "2163-0402",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Rebound high-pressure headache after treatment of spontaneous intracranial hypotension

T2 - MRV study

AU - Schievink, Wouter I.

AU - Maya, M. Marcel

AU - Jean-Pierre, Stacey

AU - Moser, Franklin G.

AU - Nuño, Miriam

AU - Pressman, Barry D.

PY - 2019/4/1

Y1 - 2019/4/1

N2 - BackgroundRebound high-pressure headaches may complicate treatment of spontaneous intracranial hypotension (SIH), but no comprehensive study of such patients has been reported and little is known about its frequency and risk factors. We therefore studied patients undergoing treatment for SIH and performed magnetic resonance venography (MRV) to assess for cerebral venous sinus stenosis, a risk factor for idiopathic intracranial hypertension.MethodsWe studied a consecutive group of patients who underwent treatment for SIH. Rebound high-pressure headache was defined as a reverse orthostatic headache responsive to acetazolamide. MRV was obtained in all patients and lateral sinus stenosis was scored according to the system published by Higgins et al., with 0 being normal and 4 signifying bilateral signal gaps.ResultsThe mean age of the 46 men and 67 women was 45.9 years (range 13-71 years) at the time of onset of SIH. Rebound high-pressure headache was diagnosed in 31 patients (27.4%); 14% of patients with an MRV score of 0, 24% with a score of 1, and 46% with a score of 2 or 3 (p = 0.0092). Also, compared to SIH patients who did not develop rebound high-pressure headaches (n = 82), those with rebound high-pressure headaches were younger, more often female, and more often had an extradural CSF collection on spinal imaging.ConclusionsRebound high-pressure headache occurs in about one-fourth of patients following treatment of SIH and is more common in those with restriction of cerebral venous outflow.

AB - BackgroundRebound high-pressure headaches may complicate treatment of spontaneous intracranial hypotension (SIH), but no comprehensive study of such patients has been reported and little is known about its frequency and risk factors. We therefore studied patients undergoing treatment for SIH and performed magnetic resonance venography (MRV) to assess for cerebral venous sinus stenosis, a risk factor for idiopathic intracranial hypertension.MethodsWe studied a consecutive group of patients who underwent treatment for SIH. Rebound high-pressure headache was defined as a reverse orthostatic headache responsive to acetazolamide. MRV was obtained in all patients and lateral sinus stenosis was scored according to the system published by Higgins et al., with 0 being normal and 4 signifying bilateral signal gaps.ResultsThe mean age of the 46 men and 67 women was 45.9 years (range 13-71 years) at the time of onset of SIH. Rebound high-pressure headache was diagnosed in 31 patients (27.4%); 14% of patients with an MRV score of 0, 24% with a score of 1, and 46% with a score of 2 or 3 (p = 0.0092). Also, compared to SIH patients who did not develop rebound high-pressure headaches (n = 82), those with rebound high-pressure headaches were younger, more often female, and more often had an extradural CSF collection on spinal imaging.ConclusionsRebound high-pressure headache occurs in about one-fourth of patients following treatment of SIH and is more common in those with restriction of cerebral venous outflow.

UR - http://www.scopus.com/inward/record.url?scp=85073617053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073617053&partnerID=8YFLogxK

U2 - 10.1212/CPJ.0000000000000550

DO - 10.1212/CPJ.0000000000000550

M3 - Article

AN - SCOPUS:85073617053

VL - 9

SP - 93

EP - 100

JO - Neurology: Clinical Practice

JF - Neurology: Clinical Practice

SN - 2163-0402

IS - 2

ER -